Association for Molecular Pathology to Provide Preliminary Analysis of the FDA’s Final Rule on Laboratory Developed Testing Procedures

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, will host a free webinar on the US Food and Drug Administration (FDA) final rule that seeks to regulate laboratory developed tests (LDTs) as medical devices.